G. Grossi

发表

Inherent insulin sensitivity is a major determinant of multimeric adiponectin responsiveness to short-term weight loss in extreme obesity

P. Marzullo, A. Brunani, M. Scacchi, 2014, Scientific Reports.

Effectiveness and safety of switching to entecavir hepatitis B patients developing kidney dysfunction during tenofovir

P. Lampertico, T. Santantonio, F. Bronte, 2019, Liver international : official journal of the International Association for the Study of the Liver.

Treatment of hepatitis B: Is there still a role for interferon?

P. Lampertico, M. Viganò, A. Loglio, 2018, Liver international (Print).

Review article: the potential of interferon and nucleos(t)ide analogue combination therapy in chronic hepatitis B infection

P. Lampertico, M. Viganò, F. Invernizzi, 2016, Alimentary pharmacology & therapeutics.

TLR7 Agonist Increases Responses of Hepatitis B Virus-Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues.

A. Mangia, P. Lampertico, M. Brunetto, 2018, Gastroenterology.

Combined sequential use of HAP and ART scores to predict survival outcome and treatment failure following chemoembolization in hepatocellular carcinoma: a multi-center comparative study

M. Kudo, T. Arizumi, J. Jang, 2016, Oncotarget.

Reactivation of hepatitis B virus during targeted therapies for cancer and immune-mediated disorders

P. Lampertico, G. Casella, M. Viganò, 2016, Expert opinion on biological therapy.

Lamivudine prophylaxis prevents hepatitis B virus reactivation in anti-HBc positive patients under rituximab for non-Hodgkin lymphoma.

L. Baldini, P. Lampertico, P. Corradini, 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Failure of long-term lamivudine prophylaxis in patients with resolved hepatitis B infection undergoing chemotherapy and allogenic hematopoietic stem cell transplantation for hematological malignancies: two case reports

P. Lampertico, R. Cairoli, V. Montefusco, 2017, Haematologica.

Tenofovir alafenamide (TAF) treatment of HBV, what are the unanswered questions?

P. Lampertico, M. Viganò, A. Loglio, 2018, Expert review of anti-infective therapy.

The prognosis and management of inactive HBV carriers

P. Lampertico, M. Viganò, F. Invernizzi, 2016, Liver international : official journal of the International Association for the Study of the Liver.

Hepatitis B virus long‐term impact of antiviral therapy nucleot(s)ide analogues (NUCs)

P. Lampertico, M. Viganò, A. Loglio, 2017, Liver international : official journal of the International Association for the Study of the Liver.

Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B

M. Ferracin, M. Massari, B. Montanini, 2017, Nature Medicine.

Comparative efficacy of sorafenib versus best supportive care in recurrent hepatocellular carcinoma after liver transplantation: a case-control study.

L. Mariani, V. Mazzaferro, A. Germini, 2013, Journal of hepatology.

Voluminous oesophageal bronchogenic cyst treated with thoracoscopic approach.

R. Boldorini, A. Oldani, M. Garavoglia, 2015, Annali italiani di chirurgia.

Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous daa failure.

A. Alberti, P. Lampertico, P. Pozzoni, 2019, Journal of hepatology.

Early activation of interferon-stimulated genes in human liver allografts: relationship with acute rejection and histological outcome

C. Avellini, M. Pirisi, C. Fabris, 2011, Journal of Gastroenterology.

Preliminary qualification of a novel, hypoxic-based radiologic signature for trans-arterial chemoembolization in hepatocellular carcinoma

Rohini Sharma, D. Pinato, M. Pirisi, 2018, BMC Cancer.

Evaluation of the red cell distribution width as a biomarker of early mortality in hepatocellular carcinoma.

Rohini Sharma, D. Pinato, M. Pirisi, 2015, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Clinical features and outcomes of hepatocellular carcinoma in Caucasian cirrhotic patients on long‐term analogue therapy for hepatitis B

M. Colombo, P. Lampertico, M. Viganò, 2018, Alimentary pharmacology & therapeutics.

Tenofovir alafenamide as a rescue therapy in a patient with HBV-cirrhosis with a history of Fanconi syndrome and multidrug resistance.

P. Lampertico, A. Gaggar, E. Galmozzi, 2017, Journal of hepatology.

P0655 : Lamivudine prophylaxis prevents hepatitis B reactivation in HBsAg-negative/anti-HBc-positive patients undergoing Rituximab-based chemotherapy for non-Hodgkin's B cell lymphoma

L. Baldini, P. Lampertico, M. Colombo, 2015 .

Preliminary qualification of a novel, hypoxic-based radiologic signature for trans-arterial chemoembolization in hepatocellular carcinoma

Rohini Sharma, D. Pinato, M. Pirisi, 2018, BMC Cancer.

Lamivudine prophylaxis prevents hepatitis b reactivation in HBsAg-negative/anti-HBc-positive patients undergoing Rituximab-based chemotherapy for non–hodgkin's B cell lymphoma

L. Baldini, P. Lampertico, P. Corradini, 2015 .

Extended survival of patients with persistently suppressed hepatitis B transplanted for hepatocellular carcinoma

V. Mazzaferro, P. Lampertico, A. Facciorusso, 2015, Liver international : official journal of the International Association for the Study of the Liver.

Comp arative efficacy of sorafenib vs. best supporti ve care in recurren t hepat ocellula r carcinoma after liver tran splantation: A case-contro l study

L. Mariani, V. Mazzaferro, A. Germini, 2013 .

IFNL4 rs368234815 and rs117648444 variants predict off‐treatment HBsAg seroclearance in IFN‐treated HBeAg‐negative chronic hepatitis B patients

P. Lampertico, E. Galmozzi, M. Viganò, 2018, Liver international : official journal of the International Association for the Study of the Liver.